Health Care & Life Sciences » Pharmaceuticals | Novartis AG

Novartis AG

Novartis AG
Stock Exchange Other OTC
EPS
 $5.27
Market Cap
 $206.19 B
Shares Outstanding
 2.55 B
Public Float
 -
Novartis AG
Stock Exchange Xetra Stock Exchange
EPS
 EUR4.49
Market Cap
 EUR183.81 B
Shares Outstanding
 2.55 B
Public Float
 -
Novartis AG ADR
Stock Exchange Mexican Stock Exchange
EPS
 MXN102.01
Market Cap
 MXN4 T
Shares Outstanding
 2.32 B
Public Float
 -
Novartis AG ADR
Stock Exchange New York Stock Exchange
EPS
 $5.26
Market Cap
 $206.92 B
Shares Outstanding
 2.53 B
Public Float
 2.55 B
Novartis AG
Stock Exchange SIX Swiss Exchange
EPS
 CHF5.75
Market Cap
 CHF208.23 B
Shares Outstanding
 2.55 B
Public Float
 2.3 B

Profile

Address
Lichtstrasse 35
Basel Basel-Stadt (Basle Town) 4056
Switzerland
Employees -
Website http://www.novartis.com
Updated 07/08/2019
Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals.

Financials

View All
Created with Highcharts 5.0.14Novartis AGNet Income. Fiscal year is January-December. All values CHF Millions.8 5228 5229 7569 7566 7576 7576 6126 6127 5827 58212 34212 34220132014201520162017201802.5k5k7.5k10k12.5k15k
Created with Highcharts 5.0.14Novartis AGSales/Revenue. Fiscal year is January-December. All values CHF Millions.48 29148 29147 98547 98547 60547 60547 79847 79848 33648 33650 79350 793201320142015201620172018010k20k30k40k50k60k

Jörg Reinhardt
Independent Non-Executive Chairman
Frans van Houten
Independent Non-Executive Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.